Swiss National Bank
SLS icon

Swiss National Bank’s SELLAS Life Sciences SLS Stock Holding History

Swiss National Bank’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32M Buy
+360,400
New +$2.49M ﹤0.01% 1408

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Swiss National Bank's SLS Position: Q2 2026 in Review

Swiss National Bank opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 360,400 shares worth $5.32M. The stake represents ﹤0.01% of the portfolio and ranks #1408 among its holdings.

101 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Swiss National Bank held 360,400 shares of SELLAS Life Sciences worth $5.32M as of Q2 2026.
  • SELLAS Life Sciences was a new Swiss National Bank position in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1408 holding.
  • 101 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.